SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Product and Process Innovation in the Development Cycle of Biopharmaceuticals
13 references·0 citing·45 second hop
Product and Process Innovation in the Development Cycle of Biopharmaceuticals (2015)Product and Process Innovation in the Dev…Assessing coreness and intermediarity of technology sectors using patent co-classification analysis: the case of Korean national R&D (2013)Assessing coreness and interm…Patent co-citation networks of Fortune 500 companies (2011)Patent co-citation networks o…How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)How to improve R&D productivi…Measuring technological diversification: identifying the effects of patent scale and patent scope (2009)Measuring technological diver…Cancer, Viruses, and Mass Migration: Paul Berg’s Venture into Eukaryotic Biology and the Advent of Recombinant DNA Research and Technology, 1967–1980 (2008)Cancer, Viruses, and Mass Mig…(Re)defining biopharmaceutical (2008)(Re)defining biopharmaceuticalPatent-bibliometric analysis on the Chinese science — technology linkages (2007)Patent-bibliometric analysis …Product and process innovation in biopharmaceuticals: a new perspective on development (2006)Product and process innovatio…Closing the innovative loop: moving from the laboratory to the shop floor in biotechnology manufacturing (2001)Closing the innovative loop: …The Dynamics of Innovation (1997)The Dynamics of InnovationThe Development Factory: Unlocking the Potential of Process Innovation (1996)The Development Factory: Unlo…Mastering the Dynamics of Innovation (1996)Mastering the Dynamics of Inn…Juran on Quality by Design: The New Steps for Planning Quality into Goods and Services (1992)Juran on Quality by Design: T…Science: The Endless Frontier (1945)The work of nations: Preparing ourselves for 21st century capitalism (1992)Networks and Organizations: Structure, Form, and Action. (1994)'Embryonic' Knowledge-based Clusters and Cities: The Case of Biotechnology in Scotland (2004)Organizational Networking in UK Biotechnology Clusters (2005)Commercialization strategies of young biotechnology firms: An empirical analysis of the U.S. industry (2008)Invention and Economic Growth (1966)Inside the Black Box: Technology and Economics (1983)Patent Statistics as Economic Indicators: A Survey (1990)Knowledge-based innovation and collaboration: a triple-helix approach in Saudi Arabia (2011)Measuring science–technology interactions using patent citations and author-inventor links: an exploration analysis from Chinese nanotechnology (2011)Topic-linked innovation paths in science and technology (2020)Fuzzy sets (1965)Case Study Research: Design and Methods (1984)Fuzzy sets (1996)How do internal capabilities and external partnerships affect innovativeness? (2008)R&D as a determinant of innovation in manufacturing SMEs: An attempt at empirical clarification (2009)Uncovering the reciprocal complementarity between product and process innovation (2016)Technological Opportunity and Spillovers of R&D: Evidence from Firms' Patents, Profits and Market Value (1986)Decision making with dependence and feedback : the analytic network process (1996)The NBER Patent Citation Data File: Lessons, Insights and Methodological Tools (2001)Tracing evolving trends in printed electronics using patent information (2014)Patent Citations Analysis and Its Value in Research Evaluation: A Review and a New Approach to Map Technology-relevant Research (2017)Analysis of technological knowledge stock and prediction of its future development potential: The case of lithium-ion batteries (2019)A Proof for the Queuing Formula: L = λ W (1961)The Goal: A Process of Ongoing Improvement (1984)Can the pharmaceutical industry reduce attrition rates? (2004)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)Investigating the sources of process innovation among UK manufacturing firms (2006)Stylized Facts in the Geography of Innovation (2010)The complexity and cost of vaccine manufacturing – An overview (2017)Recent Evolutionary Theorizing About Economic Change (2000)The Incumbent's Curse? Incumbency, Size, and Radical Product Innovation (2000)Innovation in Governance and Public Services: Past and Present (2005)Employment Effects of Product and Process Innovation in Europe (2002)The role of accessibility for the performance of regional innovation systems (2004)Innovation: a factor explaining e-government success in Estonia (2012)Controlling Off-Label Medication Use (2009)Knowledge-flows and firm performance (2012)Forecasting of emerging therapeutic monoclonal antibodies patents based on a decision model (2018)A framework for analysis of data quality research (1995)Leadership Process Models: A Review and Synthesis (2016)Design of experiments (DoE) in pharmaceutical development (2017)
this work references cited by second hop

References

  • 2010How to improve R&D productivity: the pharmaceutical industry's grand challenge3,562 cited
  • 1996Mastering the Dynamics of Innovation2,500 cited
  • 1992Juran on Quality by Design: The New Steps for Planning Quality into Goods and Services609 cited
  • 1996The Development Factory: Unlocking the Potential of Process Innovation352 cited
  • 2008(Re)defining biopharmaceutical201 cited
  • 1997The Dynamics of Innovation134 cited
  • 2013Assessing coreness and intermediarity of technology sectors using patent co-classification analysis: the case of Korean national R&D83 cited
  • 2006Product and process innovation in biopharmaceuticals: a new perspective on development81 cited
  • 2007Patent-bibliometric analysis on the Chinese science — technology linkages73 cited
  • 2001Closing the innovative loop: moving from the laboratory to the shop floor in biotechnology manufacturing66 cited
  • 2011Patent co-citation networks of Fortune 500 companies57 cited
  • 2009Measuring technological diversification: identifying the effects of patent scale and patent scope32 cited
  • 2008Cancer, Viruses, and Mass Migration: Paul Berg’s Venture into Eukaryotic Biology and the Advent of Recombinant DNA Research and Technology, 1967–198030 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work